NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $1.19 million. The enterprise value is $3.56 million.
Important Dates
The next estimated earnings date is Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 2.27 million shares outstanding.
| Current Share Class | 2.27M |
| Shares Outstanding | 2.27M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +116.00% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 0.50% |
| Float | 2.27M |
Valuation Ratios
The trailing PE ratio is 0.00.
| PE Ratio | 0.00 |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.20 |
| EV / Sales | 0.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.43 |
| Quick Ratio | 2.96 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.51 |
Financial Efficiency
Return on equity (ROE) is 160.54% and return on invested capital (ROIC) is -32.64%.
| Return on Equity (ROE) | 160.54% |
| Return on Assets (ROA) | -23.10% |
| Return on Invested Capital (ROIC) | -32.64% |
| Return on Capital Employed (ROCE) | -20.16% |
| Weighted Average Cost of Capital (WACC) | 7.77% |
| Revenue Per Employee | $60,204 |
| Profits Per Employee | $229,475 |
| Employee Count | 76 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 17.95 |
Taxes
| Income Tax | -486,706 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.94% in the last 52 weeks. The beta is -0.00, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -99.94% |
| 50-Day Moving Average | 1.30 |
| 200-Day Moving Average | 34.10 |
| Relative Strength Index (RSI) | 27.73 |
| Average Volume (20 Days) | 123,958 |
Short Selling Information
The latest short interest is 10,974, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 10,974 |
| Short Previous Month | 64,198 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $4.58 million and earned $17.44 million in profits. Earnings per share was $382.80.
| Revenue | 4.58M |
| Gross Profit | 970,956 |
| Operating Income | -6.84M |
| Pretax Income | 16.90M |
| Net Income | 17.44M |
| EBITDA | -6.80M |
| EBIT | -6.84M |
| Earnings Per Share (EPS) | $382.80 |
Full Income StatementBalance Sheet
The company has $3.15 million in cash and $5.50 million in debt, with a net cash position of -$2.35 million or -$1.03 per share.
| Cash & Cash Equivalents | 3.15M |
| Total Debt | 5.50M |
| Net Cash | -2.35M |
| Net Cash Per Share | -$1.03 |
| Equity (Book Value) | 28.74M |
| Book Value Per Share | 204.69 |
| Working Capital | 3.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.14 million and capital expenditures -$99,185, giving a free cash flow of -$15.24 million.
| Operating Cash Flow | -15.14M |
| Capital Expenditures | -99,185 |
| Free Cash Flow | -15.24M |
| FCF Per Share | -$6.70 |
Full Cash Flow StatementMargins
Gross margin is 21.22%, with operating and profit margins of -149.54% and 381.16%.
| Gross Margin | 21.22% |
| Operating Margin | -149.54% |
| Pretax Margin | 369.43% |
| Profit Margin | 381.16% |
| EBITDA Margin | -148.65% |
| EBIT Margin | -149.54% |
| FCF Margin | n/a |
Dividends & Yields
NewGenIvf Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1,447.01% |
| FCF Yield | -1,264.36% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 167.43% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on January 26, 2026. It was a reverse split with a ratio of 1:3.
| Last Split Date | Jan 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
NewGenIvf Group has an Altman Z-Score of 0.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.63 |
| Piotroski F-Score | 3 |
